Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. GOOG
6. CSX
7. IBM
8. KNX
9. LVS
10. INTC

Go back to Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron
(NYSE: NSRX) Delayed: 2.90 -0.01 (0.34%)
Previous Close $2.91    52 Week High $ 
Open $2.90    52 Week Low $ 
Day High $2.95    P/E N/A 
Day Low $2.90    EPS $ 
Volume 6,274